A multi-centre, randomised clinical trial examining the effect of Clopidogrel versus Aspirin in addition to optimal medical therapy for heart failure on subsequent heart failure hospitalisation and mortality in patients with class III-IV congestive heart failure.

Trial Profile

A multi-centre, randomised clinical trial examining the effect of Clopidogrel versus Aspirin in addition to optimal medical therapy for heart failure on subsequent heart failure hospitalisation and mortality in patients with class III-IV congestive heart failure.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms CACHE
  • Most Recent Events

    • 30 Jan 2014 Accrual to date is 2% according to United Kingdom Clinical Research Network record.
    • 30 Jan 2014 Planned End Date changed from 31 Aug 2016 to 21 Jan 2013 according to United Kingdom Clinical Research Network record .
    • 30 Jan 2014 Status changed from active, no longer recruiting to completed according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top